TY - JOUR
T1 - Histological assessment of a novel restorative coronary artery bypass graft in a chronic ovine model
AU - Sato, Yu
AU - Kutnya, Matthew
AU - Abebe, Biniyam
AU - El Kurdi, Mohammed S.
AU - Cox, Martijn
AU - Bianco, Richard W.
AU - Meuris, Bart
AU - Onuma, Yoshinobu
AU - Serruys, Patrick W.
AU - Virmani, Renu
N1 - Publisher Copyright:
Copyright © 2025 Sato, Kutnya, Abebe, El Kurdi, Cox, Bianco, Meuris, Onuma, Serruys and Virmani.
PY - 2025
Y1 - 2025
N2 - Background: Although prosthetic conduits for coronary artery bypass grafting (CABG) are increasingly needed because of the limited availability and patency of autologous conduits, no alternatives have succeeded. Methods: Sixteen sheep underwent CABG. Thirteen received a bioabsorbable polymer graft with an incorporated nitinol microskeleton (Xeltis coronary artery bypass graft [XABG]), and three received autologous saphenous vein grafts (SVG). Pathological evaluation was conducted at 12 months. Results: In the XABG group, two sheep died perioperatively; two were sacrificed at 3 months (1 occluded, 1 patent) and two at 6 months (both patent). Two more died from occlusion at 9–10 months, and five survived with patent grafts at 12 months. All SVGs remained patent for 12 months. Histology demonstrated near-complete luminal endothelialization in XABG, with increased polymer adsorption and matrix deposition. The cross-sectional area of the SVG lumen was significantly larger than XABGs (48.2 mm2 vs 12.9 mm2, p = 0.0018), consistent with a reduced angiographic flow velocity in SVG. The neointimal area was greater in SVGs than XABGs (19.6 vs. 6.7 mm2, p = 0.0005), especially at the distal ends of SVGs due to thrombus formation. Conclusion: XABG demonstrated 1-year feasibility with consistent endothelialization and polymer absorption. While SVGs had better patency, they showed greater diametrical irregularity and subsequent neointimal proliferation.
AB - Background: Although prosthetic conduits for coronary artery bypass grafting (CABG) are increasingly needed because of the limited availability and patency of autologous conduits, no alternatives have succeeded. Methods: Sixteen sheep underwent CABG. Thirteen received a bioabsorbable polymer graft with an incorporated nitinol microskeleton (Xeltis coronary artery bypass graft [XABG]), and three received autologous saphenous vein grafts (SVG). Pathological evaluation was conducted at 12 months. Results: In the XABG group, two sheep died perioperatively; two were sacrificed at 3 months (1 occluded, 1 patent) and two at 6 months (both patent). Two more died from occlusion at 9–10 months, and five survived with patent grafts at 12 months. All SVGs remained patent for 12 months. Histology demonstrated near-complete luminal endothelialization in XABG, with increased polymer adsorption and matrix deposition. The cross-sectional area of the SVG lumen was significantly larger than XABGs (48.2 mm2 vs 12.9 mm2, p = 0.0018), consistent with a reduced angiographic flow velocity in SVG. The neointimal area was greater in SVGs than XABGs (19.6 vs. 6.7 mm2, p = 0.0005), especially at the distal ends of SVGs due to thrombus formation. Conclusion: XABG demonstrated 1-year feasibility with consistent endothelialization and polymer absorption. While SVGs had better patency, they showed greater diametrical irregularity and subsequent neointimal proliferation.
KW - coronary artery bypass grafting
KW - coronary artery disease
KW - large animal model
KW - ovine model
KW - saphenous vein graft
KW - small diameter vascular graft
KW - tissue-engineered vascular graft
UR - https://www.scopus.com/pages/publications/85218412369
UR - https://www.scopus.com/inward/citedby.url?scp=85218412369&partnerID=8YFLogxK
U2 - 10.3389/fbioe.2025.1488794
DO - 10.3389/fbioe.2025.1488794
M3 - Article
C2 - 39995595
AN - SCOPUS:85218412369
SN - 2296-4185
VL - 13
JO - Frontiers in Bioengineering and Biotechnology
JF - Frontiers in Bioengineering and Biotechnology
M1 - 1488794
ER -